Citation 77730

MIMAKI,Y: KANMOTO,T: KURODA,M: SASHIDA,Y: SATOMI,Y: NISHINO,A: NISHINO,H:. (1996). STEROIDAL SAPONINS FROM HOSTA LONGIPES AND THEIR INHIBITORY ACTIVITY ON TUMOUR PROMOTER-INDUCED PHOSPHOLIPID METABOLISM OF HELA CELLS.. 42(4)

Citation Details

TitleSTEROIDAL SAPONINS FROM HOSTA LONGIPES AND THEIR INHIBITORY ACTIVITY ON TUMOUR PROMOTER-INDUCED PHOSPHOLIPID METABOLISM OF HELA CELLS.
AuthorsMIMAKI,Y: KANMOTO,T: KURODA,M: SASHIDA,Y: SATOMI,Y: NISHINO,A: NISHINO,H:
Year1996
Volume42
Issue4

Summary

Year: 1996

Journal: Unknown

Organisms and Their Experiments (1)

Hosta longipes (LILIACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified
VOUCHER SPECIMEN REPORTED FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
GITOGENIN-3-O-[ALPHA-L-RHAMNOPYRANOSYL(1-2)-BETA-D-GALACTOPYRANOSIDE]
None
2
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
GITOGENIN-3-O-[ALPHA-L-RHAMNOPYRANOSYL(1-2)-BETA-D-GALACTOPYRANOSIDE]
ACTIVE
3Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
GITOGENIN-3-O-[ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-[BETA-D-GLUCOPYRANOSYL(1-4)]-BETA-D-GALACTOPYRANOSIDE]
None
4Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
TIGOGENIN-3-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-[BETA-D-GLUCOPYRANOSYL(1-4)]-BETA-D-GALACTOPYRANOSIDE]
None
5
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
GITOGENIN-3-O-[ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-[BETA-D-GLUCOPYRANOSYL(1-4)]-BETA-D-GALACTOPYRANOSIDE]
EQUIVOCAL
6
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
TIGOGENIN-3-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-[BETA-D-GLUCOPYRANOSYL(1-4)]-BETA-D-GALACTOPYRANOSIDE]
ACTIVE
7Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
FUROSTANE,5-ALPHA: 26-O-BETA-D-GLUCOPYRANOSYL-22-O-METHYL: 2-ALPHA-3-BETA-22-EPSILON-26-TETROL-3-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-BETA-D-GALACTOPYRANOSIDE] 25(R):
None
8Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
FUROSTANE-2-ALPHA-3-BETA-22-EPSILON-26-TETROL,5-ALPHA: 26-O-BETA-D-GLUCOPYRANOSYL-22-O-METHYL: 3-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-[BETA-D-GLUCOPYRANOSYL(1-4)]-BETA-D-GALACTOPYRANOSIDE] 25(R):
None
9
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
FUROSTANE,5-ALPHA: 26-O-BETA-D-GLUCOPYRANOSYL-22-O-METHYL: 2-ALPHA-3-BETA-22-EPSILON-26-TETROL-3-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-BETA-D-GALACTOPYRANOSIDE] 25(R):
INACTIVE
10
ANTITUMOR-PROMOTING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
FUROSTANE-2-ALPHA-3-BETA-22-EPSILON-26-TETROL,5-ALPHA: 26-O-BETA-D-GLUCOPYRANOSYL-22-O-METHYL: 3-O-[O-ALPHA-L-RHAMNOPYRANOSYL(1-2)-O-[BETA-D-GLUCOPYRANOSYL(1-4)]-BETA-D-GALACTOPYRANOSIDE] 25(R):
INACTIVE
Show SPARQL Queries (1)